Home > National Drug Code (NDC) > Lansoprazole

Lansoprazole - 51991-771-33 - (Lansoprazole)

Alphabetical Index


Drug Information of Lansoprazole

Product NDC: 51991-771
Proprietary Name: Lansoprazole
Non Proprietary Name: Lansoprazole
Active Ingredient(s): 15    mg/1 & nbsp;   Lansoprazole
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Lansoprazole

Product NDC: 51991-771
Labeler Name: Breckenridge Pharmaceutical, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA201921
Marketing Category: ANDA
Start Marketing Date: 20121218

Package Information of Lansoprazole

Package NDC: 51991-771-33
Package Description: 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (51991-771-33)

NDC Information of Lansoprazole

NDC Code 51991-771-33
Proprietary Name Lansoprazole
Package Description 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (51991-771-33)
Product NDC 51991-771
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lansoprazole
Dosage Form Name CAPSULE, DELAYED RELEASE
Route Name ORAL
Start Marketing Date 20121218
Marketing Category Name ANDA
Labeler Name Breckenridge Pharmaceutical, Inc.
Substance Name LANSOPRAZOLE
Strength Number 15
Strength Unit mg/1
Pharmaceutical Classes Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA]

Complete Information of Lansoprazole


General Information